Christopher Peetz, President and CEO at Mirum Pharmaceuticals, Inc. (MIRM), bought 13,820 shares at $10.91 ($152K) on 2019-09-06, disclosed to the SEC on 2019-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.91 | 4,750 | $52K | 34.1% |
| 2 | $10.91 | 4,750 | $52K | 34.1% |
| 3 | $10.90 | 2,000 | $22K | 14.4% |
| 4 | $11.35 | 2,320 | $26K | 17.3% |
| Total | $10.98 avg | 13,820 | $152K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |